Skip to content
ppharmaranks
Menu
Class IIOngoing

Testosterone recall

FDA recall D-0324-2026 · initiated Jan 26, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Feb 18, 2026How we research

F.H. INVESTMENTS, Inc. (dba Asteria Health) recalled Testosterone in Jan 2026 — an FDA Class II recall (D-0324-2026) because Presence of Foreign substance - potential presence of metal particulate matter.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Foreign substance - potential presence of metal particulate matter

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot#: 251000127, Exp. 06/03/2026; 251000128, Exp. 06/05/2026; 251000133, 251000134, 251000135, Exp. 06/16/2026; 251000138, 251000139, 251000140, 251000141, Exp. 06/25/2026; 251000147, 251000148, 251000149, Exp. 07/28/2026; 251000156, 251000157, Exp. 08/08/2026; 251000164, 251000165, 251000166, Exp. 08/22/2026; 251000169, Exp. 08/29/2026; 251000171, 251000172, Exp. 09/03/2026; 251000180, Exp. 09/19/2026.

Quantity recalled: 194,336 pellets

Details

Product
Testosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.
Recalling company
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Jan 26, 2026
FDA report date
Feb 18, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Testosterone recalled?
F.H. INVESTMENTS, Inc. (dba Asteria Health) recalled Testosterone in Jan 2026 — an FDA Class II recall (D-0324-2026) because Presence of Foreign substance - potential presence of metal particulate matter. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Testosterone recalled?
Per the FDA enforcement record, the reason for recall D-0324-2026 was: Presence of Foreign substance - potential presence of metal particulate matter
Is a recalled Testosterone dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Testosterone are affected?
Distributed: Nationwide in the USA. The recall covers these lots — Lot#: 251000127, Exp. 06/03/2026; 251000128, Exp. 06/05/2026; 251000133, 251000134, 251000135, Exp. 06/16/2026; 251000138, 251000139, 251000140, 251000141, Exp. 06/25/2026; 251000147, 251000148, 251000149, Exp. 07/28/2026; 251000156, 251000157, Exp. 08/08/2026; 251000164, 251000165, 251000166, Exp. 08/22/2026; 25100016…. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0324-2026.

Source: openFDA Drug Enforcement record D-0324-2026

← All drug recalls